Description
Product Overview
Dermorphin is a defined heptapeptide characterised by the sequence Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2. A distinctive structural feature is the presence of D-alanine at position 2, together with a C-terminal amide.
Pronoia supplies Dermorphin as a 10mg lyophilised research peptide for laboratory research, analytical investigation and controlled experimental use.
Product Specification
Product: Dermorphin
Strength: 10mg
Peptide class: Heptapeptide
Form: Lyophilised solid
Sequence: H-Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2
Structural feature: D-alanine at position 2; C-terminal amide
Pronoia minimum purity standard: ≥98%
Storage: Temperature-controlled cold storage
Intended use: Laboratory research only
Quality, Testing & Traceability
Pronoia maintains a structured quality and traceability process across its research catalogue.
- Supplier analytical documentation retained
- Independent third-party laboratory testing
- Minimum accepted purity standard of 98%
- Full batch traceability
- Batch-separated and labelled inventory
- Physical stock reconciled with digital inventory
- Temperature-controlled cold storage
- Certificate of Analysis and Safety Data Sheet maintained for each product
Batch-specific documentation can normally be provided by Pronoia within 24 hours of a documentation request.
Research Context
Dermorphin has a long history as a defined research peptide in biochemical, pharmacological and receptor-characterisation studies.
Experimental research involving Dermorphin has included:
- Opioid-receptor binding and receptor-selectivity studies
- Peptide structure–activity relationship research
- Investigation of the contribution of D-amino-acid residues to peptide behaviour
- Comparative studies of dermorphin fragments and structural analogues
- Peptide conformation and molecular-interaction research
These areas describe laboratory and experimental research contexts only and do not imply suitability for human or veterinary use.
Storage & Handling
Dermorphin is supplied in lyophilised form and should be handled using appropriate laboratory procedures.
Pronoia stock is maintained in temperature-controlled cold storage and organised by identifiable batch prior to dispatch.
Consult the relevant Safety Data Sheet and batch documentation for product-specific storage and handling information. Receiving laboratories should apply their own validated procedures.
Delivery & Documentation
Pronoia uses tracked Royal Mail services and discreet packaging for dispatched orders.
Monday–Thursday: Orders with cleared payment received before 3pm UK time are dispatched the same working day.
Friday: Same-day dispatch is available where the Saturday Guaranteed delivery option is selected and the applicable acceptance cut-off can be met. Standard Friday and weekend orders are held securely in Pronoia’s temperature-controlled storage and dispatched Monday morning.
Temperature-conscious packaging: Available as an optional paid addition.
Tracking information is provided for dispatched orders. COA, SDS and batch-documentation enquiries can normally be fulfilled within 24 hours.
Research Use Statement
For laboratory research use only.
This material is not supplied for human or veterinary use, diagnosis, treatment, prevention of disease or any other therapeutic application. Pronoia does not provide dosage, treatment or administration guidance.
